Published • loading... • Updated
Medicines: in Difficulty, the Manufacturer Euroapi Burys His Project in Normandy
Summary by latribune.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The active ingredient specialist for the pharmaceutical industry plans to decrease his activity by 10% in 2026. L的ex-subsidiary of Sanofi intends to accelerate its restructuring and stops its plan to increase the production capacity of vitamin B12 in Saint-Aubin-les-Elbeuf.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
